As Bicara Therapeutics lines up for a potential accelerated cancer drug approval next year, the biotech has appointed Chris Sarchi as its chief commercial officer. | As Bicara Therapeutics lines up ...

A Bristol-based biotech firm has made major advances towards developing a vaccine for hantavirus. EnsiliTech, based at ...

Bayer has removed a protein therapeutic for hypertension and a treatment for diabetic neuropathic pain from its phase 1 ...

Founder Patrick Soon-Shiong hinted at expansion plans in Turkey, saying on X that “Global expansion” is underway. ・Soon-Shiong also revealed that ImmunityBio’s AI-driven NK-cell manufacturing robot is ...

Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week.

But what if one of them encounters significant competition soon? That's what some investors believe might happen, given ...

An expert from Northway Biotech and Lithuania’s Minister of Economy and Innovation talk about how the country is poised to be ...

Dr. Andrew Snyder (Monash University) joins the show to discuss the current biotech landscape: rising M&A and IPO activity, ...

Animal-free dairy is entering a reset phase, with one startup abandoning the “build first, scale later” approach in favor of ...

FDA drug approvals are reshaping biotech stocks—track key decisions, FDA leadership turmoil, and volatility. Click for a look ...

The top note in a new perfume called Miami Split comes from an unexpected place: a banana processing plant in Ecuador. The ...